Is St. John’s Wort Safe for Children?

St. John’s wort has not been established as safe for children or adolescents, primarily because no randomized controlled trials have tested it in pediatric populations for its most common use, treating depression. A handful of small, open-label studies in young people showed promising mood improvements, but they lacked placebo controls and had high dropout rates, making it impossible to draw firm safety conclusions. The bigger concern is what we do know: St. John’s wort powerfully alters how the body processes dozens of medications, a problem that is potentially amplified in children whose metabolic systems are still developing.

What the Pediatric Depression Studies Actually Found

The evidence for St. John’s wort treating depression in children comes from three open-label pilot studies, meaning participants and researchers both knew what was being taken, and there was no placebo comparison. In the largest of these, a study of 33 children and adolescents with major depressive disorder, 25 met response criteria after eight weeks of treatment. The authors concluded St. John’s wort “may be an effective treatment” but emphasized that placebo-controlled trials were needed.¹ A smaller study of adolescents found that 9 out of 11 who completed the trial showed meaningful clinical improvement, though the study started with more participants and lost several along the way.²

A separate observational study looking at children under 12 with mild to moderate depressive symptoms reported that physicians rated the treatment “good” or “excellent” in all cases by six weeks. No adverse events were reported, which sounds reassuring until you notice that by the final evaluation, a quarter of the original sample had dropped out, and effectiveness ratings came only from those who stayed.³

Across all three trials, clinical changes appeared quickly, sometimes within one to two weeks. But dropout rates in two of the three studies were substantial, reaching 25% and 57%, which limits how much we can read into the overall response rates.¹ The fundamental problem is that depression responds to placebo at high rates in young people, so without a placebo arm, we cannot tell whether the herb was driving the improvements or whether the kids would have gotten better anyway. To date, no randomized controlled trial of St. John’s wort for pediatric depression has been published.

For ADHD, the Evidence Is Clearer and Not Encouraging

Unlike the depression studies, there is one well-designed randomized controlled trial of St. John’s wort for ADHD in children and adolescents. Published in JAMA, it enrolled 54 participants aged 6 to 17 and randomly assigned them to either St. John’s wort or placebo for eight weeks. The result was unambiguous: there was no meaningful difference between the two groups on any ADHD symptom measure. Improvement in the placebo group was actually slightly larger than in the treatment group, and the proportion of kids rated as “much improved” was nearly identical in both arms.⁴ A systematic review of complementary medicines for ADHD reached the same conclusion, classifying St. John’s wort as ineffective for this condition.⁵

A tiny case series of just three teenage boys did find that their scores on hyperactivity and inattention measures improved while taking the herb, but with only three participants and no blinding, this tells us next to nothing that the JAMA trial didn’t already answer more reliably.⁶ If you’re a parent considering St. John’s wort specifically for ADHD, the most rigorous study available says it doesn’t work.

Drug Interactions Are the Central Safety Concern

Even if future trials showed St. John’s wort helped with pediatric depression, its drug interaction profile would remain a serious problem. The herb is a potent activator of a liver enzyme called CYP3A4 and a transporter protein called P-glycoprotein, both of which play a role in how the body absorbs, distributes, and eliminates a huge range of medications.⁷ The practical effect is that St. John’s wort can cause other drugs to get broken down and flushed from the body much faster than intended, reducing their effectiveness or requiring higher doses to achieve the same effect.

The scale of this interaction is not subtle. One study found that after 14 days of St. John’s wort, the body cleared the anti-anxiety drug alprazolam twice as fast, cutting its half-life roughly in half. The researchers noted that this effect could diminish the clinical effectiveness of at least half of all marketed medications, since so many are processed by the same enzyme pathway.⁸ Another study measured a more than 50% drop in the blood levels of orally taken midazolam after long-term St. John’s wort use.⁹

For children, this matters because the list of medications affected includes many that pediatric patients commonly take: asthma medications, certain antibiotics, immunosuppressants used after organ transplant, seizure drugs, and psychiatric medications. A child taking a carefully dosed prescription could have that drug’s levels silently undermined by a supplement their parents picked up at a health food store.

The P-Glycoprotein Wrinkle

The interaction story gets more complicated with P-glycoprotein, a transporter protein that acts as a gatekeeper in the intestines, brain, and kidneys, pumping certain drug molecules back out of cells. St. John’s wort’s two main active compounds, hyperforin and hypericin, directly inhibit this transporter at first, then induce it over time.¹⁰ In plain terms, this means that in the first few days of taking St. John’s wort alongside another drug, you might actually absorb more of that drug than expected, as the gatekeepers get jammed open. Then, as the body ramps up production of P-glycoprotein over the following weeks, the gatekeepers overcompensate and start pumping the drug out more aggressively, leading to lower levels than normal.

This two-phase pattern, initial over-exposure followed by under-exposure, is particularly dangerous because neither direction is safe. Too much of a medication early on can cause side effects; too little later on can mean the drug stops working. Quercetin and hyperforin appear to be the most potent modulators of this transporter.¹¹ This biphasic interaction has been documented in lab settings and is consistent with clinical observations, making it especially tricky for doctors to manage even when they know about it.

A Specific Risk for Teenage Girls on Birth Control

One drug interaction that deserves its own mention involves oral contraceptives, because this scenario is uniquely relevant to adolescents. A study in women taking a standard birth control pill found that St. John’s wort significantly sped up the breakdown of both hormone components: the half-life of ethinyl estradiol was roughly cut in half, and the clearance of norethindrone increased meaningfully. Breakthrough bleeding, a sign that hormone levels have dropped too low to maintain their contraceptive effect, jumped from 2 out of 12 women during the control phase to 7 out of 12 during the St. John’s wort phase.¹²

The researchers concluded that women taking oral contraceptives alongside St. John’s wort should add a barrier method of contraception. For a teenager who may already have less consistent health care oversight and who may not disclose supplement use to their gynecologist, the risk of unintended pregnancy from a supplement they consider “natural” and therefore harmless is real and preventable.

Serotonin Syndrome When Combined with Antidepressants

St. John’s wort affects brain chemistry in ways that overlap with prescription antidepressants, particularly SSRIs and other drugs that raise serotonin levels. When the herb is combined with these medications, the cumulative effect on serotonin can push the system into a dangerous state known as serotonin syndrome, which can cause agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, and in severe cases, seizures or muscle rigidity. A review of St. John’s wort drug interactions concluded that combining the herb with serotonergic agents should only happen under experienced medical supervision, if at all.¹³

This is especially relevant for children because a common scenario is a parent who tries St. John’s wort either as an alternative to prescription antidepressants or, more worryingly, alongside them. If a child is already on an SSRI and a parent adds St. John’s wort without telling the prescribing doctor, the risk of serotonin syndrome is significant. And as the data on parental disclosure shows, this is not a hypothetical concern.

Children’s Bodies Process Supplements Differently

One issue that gets overlooked in discussions of herbal supplements for children is that pediatric metabolism is not simply a scaled-down version of adult metabolism. Children’s livers, kidneys, and enzyme systems are still maturing, and the rates at which they process drugs can differ substantially from adults, sometimes faster, sometimes slower, depending on age and developmental stage. A review of herb-drug interactions in pediatric populations noted that the potential for interactions between natural health products and medications “may be increased in pediatric populations because of altered metabolism and excretion.”¹⁴

The same review pointed out that the use of natural health products among children may be as high as 70% in certain groups, especially kids with chronic conditions like asthma, ADHD, cancer, or cystic fibrosis. These are precisely the children most likely to be on other medications and therefore most vulnerable to interactions. Yet nearly all the pharmacokinetic data on St. John’s wort interactions comes from studies in adults. We are essentially guessing how these interactions play out in a child’s body, using adult data as a rough proxy.

Photosensitivity and Eye Risk

St. John’s wort contains hypericin, a compound that makes cells more vulnerable to damage from light. This photosensitizing effect is well known in adults who take the supplement and then experience sun sensitivity, but research has raised questions about deeper tissue effects. One laboratory study exposed human lens cells to hypericin and then to ultraviolet or visible light. Neither hypericin alone nor light alone caused damage, but the combination triggered cell death through both necrosis and a more programmed form called apoptosis.¹⁵

This was a lab study, not a clinical trial in living people, so the direct relevance to a child taking a standard dose and playing outside is uncertain. But children tend to spend more time outdoors than adults, and their eyes admit more UV light because the lens has not yet developed the same protective yellowing that occurs with age. The combination of higher sun exposure and a photosensitizing supplement is worth noting, even if the clinical consequences remain unstudied in pediatric populations.

Most Doctors Don’t Know Their Patients Are Taking It

Perhaps the most unsettling finding in the pediatric literature is how often children receive herbal supplements without their doctors’ knowledge. A survey of caregivers whose children had ADHD or depression found that 61% started giving herbal medicines based on a recommendation from a friend or family member. St. John’s wort was among the most commonly used herbs. Roughly 83% of caregivers gave the herbs on their own, without combining them with prescription drugs, but 13% did give herbal medicines alongside prescriptions. The most striking number: the children’s psychiatrists were unaware of the herbal use 70% of the time, pediatricians 56% of the time, and pharmacists 74% of the time.¹⁶

This gap between what parents are giving and what doctors know about creates a blind spot in clinical care. A psychiatrist adjusting a child’s medication dose has no way to account for an enzyme-inducing supplement they don’t know about. A pediatrician prescribing an antibiotic might not think to ask about herbal products. The supplement aisle at the pharmacy doesn’t come with a pharmacist consult the way the prescription counter does. If you are a parent giving your child St. John’s wort, telling every one of their health care providers is not optional. It is the single most important safety step you can take.

Accidental Ingestion in Young Children

Separate from intentional use, poison control centers receive calls about young children accidentally swallowing St. John’s wort. During 2001, poison control centers across the United States logged 356 exposures involving St. John’s wort. The majority occurred in children aged five and younger, and most were coded as unintentional.¹⁷ While serious outcomes from accidental ingestion appear to be rare, the fact that herbal supplements are often sold without child-resistant packaging and stored alongside vitamins and other household supplements makes accidental access easy. If you keep St. John’s wort in the house, store it out of reach the same way you would any medication.

Supplement Quality and Dosing Variability

In the United States, herbal supplements are regulated as dietary supplements rather than drugs, which means manufacturers do not have to prove safety or effectiveness before selling them. Independent testing has repeatedly shown that the actual content of active compounds in St. John’s wort products can vary widely from what the label claims. For adults, this is an annoyance. For children, who weigh less and whose metabolic systems are less forgiving, dosing inconsistencies carry more risk. A child receiving twice the intended dose of hyperforin because of a poorly standardized product would experience more enzyme induction, more photosensitivity, and a greater chance of drug interactions than a child on the intended dose.

None of the pediatric studies used commercially available over-the-counter products in the way a parent would buy them. They used standardized research-grade extracts with verified compositions. The St. John’s wort you can pick up at a drugstore may or may not resemble what was tested in those trials, and there is no easy way for a consumer to verify this at point of purchase.

What Parents Should Consider Instead

If you are looking into St. John’s wort because your child seems depressed, the most productive step is a conversation with their pediatrician or a child psychiatrist. Pediatric depression is treatable, and several interventions have strong evidence behind them, including cognitive behavioral therapy and, when warranted, prescription antidepressants that have been specifically studied and approved for use in children. These treatments come with monitoring protocols, known dose ranges for pediatric patients, and the ability for a prescribing doctor to adjust treatment based on response.

St. John’s wort occupies an awkward middle ground: it’s pharmacologically active enough to cause real drug interactions and side effects, but it hasn’t been rigorously tested in children to confirm it actually works. Treating it as harmless because it’s “natural” misses the point. The herb contains compounds that change how the liver processes other drugs, sensitize skin and potentially eyes to sunlight, and affect serotonin levels in the brain. Those are drug-like effects, and they deserve drug-like scrutiny, especially in growing bodies we don’t fully understand yet.